Flora Peyvandi Shares BIC 2025 Coverage of Hemostasis & Thrombosis: 10 Posts Not To Miss
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X:
Flora Peyvandi shared BIC 2025 Coverage of latest research on Hemostasis and Thrombosis fresh from the conference:
1.‘‘Wolfgang Miesbach reports the safety of HA and HB gene therapies after 5 and 4 years respectively”
2.”David Lilicrap reports the interindividual variability of gene therapy in Hemophilia at BIC2025”
3.‘‘David Lilicrap reports data on long term safety of HA gene therapy”
4.”Alessio Cantore at Bic 2025 reporting where we are standing with lentiviral gene therapy in Hemophilia”
5.”Naldini group showed clearly they are ready to go through clinical trial phase 1 for HB with lenti viral vector and what’s missing is Funding.
Why that’s happening? No more interest in GT in Hemophilia even for the cure?”
6.”Very interesting data on gene therapy as the ITI to reverse the anti factor inhibitors in mice with anti FIX inhibitors was successful bic 2025.
Data from Dr Herzog Indiana University”
7.”New gene therapy clinical trial on FVII severe deficiency by Amit Nathwani. Look forward for that!”
8.”Amy Shapiro reports a new DDAP molecule to treat patients with VWD type 1.
This is a great news due to discontinuation of intranasal Desmopressin and it shortage.
This formulation is available in US”
9.”A single dose of VGA039 in 10 patients with VWD inhibiting PS , showed good efficacy with no safety issue reported by Carolyn Millar”
10.”Michela Milani should how they created a shielded lentiviral vector to reduce the immunogenicity against FVIII in mice”
More from BIC 2025 featured in Hemostasis Today.
-
Sep 24, 2026, 16:02Leonardo R: Understanding Peripheral Artery Disease in the Modern Era
-
Sep 24, 2026, 15:49Sthanu Subramanian: When HbA1c Does Not Reflect True Glycemia
-
Sep 24, 2026, 15:09Caroline Voltz-Girolt: Accelerating the Development of Innovative Therapies for Rare Blood Disorders
-
Sep 24, 2026, 15:00Gambo Ramatu: Anemia as a Preventable Pregnancy Challenge
-
Sep 24, 2026, 14:56Holly John: Sickle Cell Disease Beyond Pain and Clinical Outcomes
-
Sep 24, 2026, 14:45Bruce Holland: Ex Vivo Assessment of ActiGraft Clot Formation Under Anticoagulation
-
Sep 24, 2026, 14:33Mohamed El Belghiti Alaoui: Thrombin as a Therapeutic Target in Coagulation
-
Sep 24, 2026, 14:22Integrating Thrombosis Risk Into Menopause Care – World Thrombosis Day
-
Sep 24, 2026, 13:41Mahmoud Samir Bayomi: Raise ITP Awareness and Improve Patient Care